ACD enters the final days of April carrying the weight of a deeply difficult 2025. Revenue fell from CAD 83 million to CAD 62 million last year, and the net loss widened to CAD 30 million — compared with just CAD 3 million the prior year. The stock reflects that pain: down 21% over the past month to CAD 1.31, even after clawing back 2.3% this week.
The most notable structural development is the April sale of the US subsidiary's loan portfolio. That move narrows the business significantly and raises immediate questions about the go-forward revenue base heading into the May reporting window. With a next scheduled update on May 11, the market has little time to wait for clarity on what the slimmed-down Accord looks like.
Short interest is not a factor here. Estimated short shares in the ORTEX model stand at roughly 178 — in absolute terms, a negligible position. Short interest as a percentage of free float registers at 0.006%, essentially zero. Borrow availability is loose: utilization has eased to just 1.3%, well below the 52-week high of 4.6% reached in February. Cost to borrow ticked up to 4.1% last week — a 45% move from the prior week — but that rise comes from an already-low base and reflects no meaningful squeeze dynamic. Short sellers are not the story.
Ownership concentration is. The top three holders — Oakwest Corporation, Hitzig Bros. Hargreaves & Co., and 3502236 Canada Inc — collectively control roughly 60% of shares outstanding. With that level of insider concentration, price discovery on thin volume can be erratic, and any institutional decision to adjust has an outsized effect on the float. The ORTEX short score registers at 26.8, ranking in the 88th percentile for short score — a function of the stock's recent price behaviour, not of active short positioning.
No current analyst coverage, options data, or fresh valuation multiples are available for ACD. The dividend history is stale, with the last declared payment dating to April 2022. The picture that emerges is of a micro-cap specialty lender in active restructuring — shedding assets, reporting large losses, and trading at a fraction of its prior price — with the next meaningful data point the May update on how the business is being repositioned post-US exit.
See the live data behind this article on ORTEX.
Open ACD on ORTEX →ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data. Content is informational only and does not constitute investment advice.
